£122.32

Academic Press Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks: Perspectives of Translational Medicine

Price data last checked 59 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£122 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 32 days • 32 data points (No recent data available)

Historical
Generating forecast...
£123.57 £122.20 £122.49 £122.79 £123.10 £123.40 £123.70 11 March 2026 18 March 2026 26 March 2026 03 April 2026 11 April 2026

Price Distribution

Price distribution over 32 days • 2 price levels

Days at Price
Current Price
8 days · current 24 days 0 6 12 18 24 £122 £124 Days at Price

Price Analysis

Most common price: £124 (24 days, 75.0%)

Price range: £122 - £124

Price levels: 2 different prices over 32 days

Description

Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks: Perspectives of Translational Medicine provides readers with cutting-edge knowledge on tumor microenvironment. By exploring multiple aspects on tumor microenvironment, it gives an integrative insight on cancer diseases ranging from diagnosis to prediction of prognosis and individualized treatment.The book discusses topics such as clinical significance of tumor microenvironment, tumorigenesis and cancer progression, histopathological features of cancer in peritoneum, immune cells in tumor, exosomal cell-to-cell interactions, and therapeutic approaches to target tumor microenvironment. Additionally, it discusses tumor evolution during chemotherapy and metastasis, and future perspectives on identification and validation of biomarkers using liquid biopsy. This book is a valuable resource for cancer researchers, oncologists, medical doctors, and several members of biomedical field who want to understand the complex microenvironment of peritoneal tumors. Review Presents recent findings on tumor microenvironment leading to diagnosis, prediction of prognosis, and individualized treatment of cancer From the Back Cover <i>Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks: Perspectives of Translational Medicine</i> provides readers with cutting-edge knowledge on tumor microenvironment. By exploring multiple aspects on tumor microenvironment, it gives an integrative insight on cancer diseases ranging from diagnosis to prediction of prognosis and individualized treatment.The book discusses topics such as clinical significance of tumor microenvironment, tumorigenesis and cancer progression, histopathological features of cancer in peritoneum, immune cells in tumor, exosomal cell-to-cell interactions, and therapeutic approaches to target tumor microenvironment. Additionally, it discusses tumor evolution during chemotherapy and metastasis, and future perspectives on identification and validation of biomarkers using liquid biopsy.<br><br>This book is a valuable resource for cancer researchers, oncologists, medical doctors, and several members of biomedical field who want to understand the complex microenvironment of peritoneal tumors. About the Author Yong Sang Song, MD, PhD is currently Professor at Seoul National University, College of Medicine. He received his MD and PhD at the Seoul National University (1983 and 1994 respectively). He was elected as the chairperson of Korean Society of Urogynecology in 2006. He was selected as the Director of Cancer Research Institute at Seoul National University in 2009, and as the President of Korean Society of Cancer Prevention in 2012. He served as the President of International Society of Precision Cancer Medicine (ISPCM) in 2018. His major research interests are molecular mechanisms of tumors, especially the role of tumor microenvironment in cancer cell metabolism, chemoresistance and precision medicine in gynecologic cancer. He is particularly interested in the impact of components of tumor microenvironment in ovarian cancer progression. Danny N. Dhanasekaran, PhD, is Samuel Roberts Noble Foundation Endowed Chair in Cancer Research. He is Deputy Director for Basic Sciences and Director, SCC-COBRE & Center for Basic Cancer Research, Stephenson Cancer Center,?University of Oklahoma Health Science Center, USA. Danny N. Dhanasekaran, PhD, is Samuel Roberts Noble Foundation Endowed Chair in Cancer Research. He is Deputy Director for Basic Sciences and Director, SCC-COBRE & Center for Basic Cancer Research, Stephenson Cancer Center,?University of Oklahoma Health Science Center, USA. Benjamin K Tsang, PhD, is Director, Reproductive Biology Unit, and Professor, Department of Obstetrics and Gynaecology and Cellular & Molecular Medicine and the Interdisciplinary School of Health Sciences, University of Ottawa, Canada. Johji Inazawa, MD, PhD, is Director, Bioresource

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
27 June 2024
Listed Since
11 January 2021

Barcode

No barcode data available

Similar Products You Might Like

Translational Advances in Gynecologic Cancers
97% match

Translational Advances in Gynecologic Cancers

Academic Press

£76.47 11 Mar 2026
Ovarian Cancer Biomarkers: Mapping to Improve Outcomes
96% match

Ovarian Cancer Biomarkers: Mapping to Improve Outcomes

Springer

£103.30 02 Apr 2026
Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)
96% match

Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)

Springer

£135.35 08 Mar 2026
Precision Medicine in Gynecology and Obstetrics (Comprehensive Gynecology and Obstetrics)
96% match

Precision Medicine in Gynecology and Obstetrics (Comprehensive Gynecology and Obstetrics)

Springer

£111.81 09 Mar 2026
Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing: A Big Chapter in the Tale
96% match

Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing: A Big Chapter in the Tale

Springer

£116.58 10 Feb 2026
The ERAS® Society Handbook for Obstetrics & Gynecology
96% match

The ERAS® Society Handbook for Obstetrics & Gynecology

Academic Press

£99.59 13 Apr 2026
Springer Uterine Cancer: Screening, Diagnosis, and Treatment
96% match

Springer Uterine Cancer: Screening, Diagnosis, and Treatment

Springer

£104.04 18 Apr 2026
Atlas of Clear Cell Carcinoma of the Ovary: A Pathological Guide
96% match

Atlas of Clear Cell Carcinoma of the Ovary: A Pathological Guide

Springer

£78.51 01 Mar 2026
Oncofertility Medical Practice: Clinical Issues and Implementation
96% match

Oncofertility Medical Practice: Clinical Issues and Implementation

Springer

£80.39 14 Apr 2026
Oncofertility Communication: Sharing Information and Building Relationships across Disciplines
96% match

Oncofertility Communication: Sharing Information and Building Relationships across Disciplines

Springer

£72.92 06 Mar 2026
Advances in Diagnosis and Management of Ovarian Cancer
96% match

Advances in Diagnosis and Management of Ovarian Cancer

Springer

£119.99 01 Mar 2026
Principles of Gynecologic Oncology Surgery
96% match

Principles of Gynecologic Oncology Surgery

Elsevier

£167.81 23 Jan 2026
Principles and Practice of Gynecologic Oncology
96% match

Principles and Practice of Gynecologic Oncology

Lippincott Williams & Wilkins

£168.64 26 Jan 2026
Springer Proteoglycans in Stem Cells: From Development to Cancer
96% match

Springer Proteoglycans in Stem Cells: From Development to Cancer

Springer

£122.85 16 Apr 2026
Ovarian Cancer: Second Edition: 149 (Cancer Treatment and Research, 149)
96% match

Ovarian Cancer: Second Edition: 149 (Cancer Treatment and Research, 149)

Springer

£80.09 09 Mar 2026
Gynecologic Cancer Care: Innovative Progress (Volume 46-1) (The Clinics: Internal Medicine, Volume 46-1)
96% match

Gynecologic Cancer Care: Innovative Progress (Volume 46-1) (The Clinics: Internal Medicine, Volume 46-1)

Elsevier

£68.41 06 Mar 2026
Atlas of Difficult Gynecological Surgery
96% match

Atlas of Difficult Gynecological Surgery

Springer

£86.42 02 Mar 2026
Ovarian Cancers: Advances through International Research Cooperation (GINECO, ENGOT, GCIG)
95% match

Ovarian Cancers: Advances through International Research Cooperation (GINECO, ENGOT, GCIG)

Springer

£109.99 10 Apr 2026
Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)
95% match

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Academic Press

£117.19 06 Mar 2026
Gynäkologische Onkologie: Manual für Klinik und Praxis
95% match

Gynäkologische Onkologie: Manual für Klinik und Praxis

Springer

£58.04 08 Apr 2026
Clinical Gynaecological Oncology: FOR LOW & MIDDLE INCOME COUNTRIES
95% match

Clinical Gynaecological Oncology: FOR LOW & MIDDLE INCOME COUNTRIES

£54.85 21 Feb 2026
Hormonal Pathology of the Uterus: 1242 (Advances in Experimental Medicine and Biology, 1242)
95% match

Hormonal Pathology of the Uterus: 1242 (Advances in Experimental Medicine and Biology, 1242)

Springer

£77.20 24 Feb 2026
Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)
95% match

Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)

Springer

£110.00 09 Mar 2026
The Tumor Microenvironment of High Grade Serous Ovarian Cancer
95% match

The Tumor Microenvironment of High Grade Serous Ovarian Cancer

MDPI AG

£64.85 19 Apr 2026